Measurement of colorectal cancer test use with medical claims data in a safety-net health system

Samir Gupta, Liyue Tong, Paula Anderson, Bonnie Rose, Elizabeth Carter, Mark Koch, Keith Argenbright, Chul Ahn, James Allison, Celette Sugg Skinner

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

BACKGROUND: Optimizing colorectal cancer (CRC) screening requires identification of unscreened individuals and tracking screening trends. A recent National Institutes of Health State of the Science Conference, "Enhancing Use and Quality of CRC Screening," cited a need for more population data sources for measurement of CRC screening, particularly for the medically underserved. Medical claims data (claims data) are created and maintained by many health systems to facilitate billing for services rendered and may be an efficient resource for identifying unscreened individuals. The aim of this study, conducted at a safety-net health system, was to determine whether CRC test use measured by claims data matches medical chart documentation. METHODS: The authors randomly selected 400 patients from a universe of 20,000 patients previously included in an analysis of CRC test use based on claims data 2002-2006 in Tarrant Co, TX. Claims data were compared with medical chart documentation by estimation of agreement and examination of test use over/underdocumentation. RESULTS: The authors found that agreement on test use was very good for fecal occult blood testing (κ = 0.83, 95% confidence interval: 0.75-0.90) and colonoscopy (κ = 0.91, 95% confidence interval: 0.85-0.96) and fair for sigmoidoscopy (κ = 0.39, 95% confidence interval: 0.28-0.49). Over- and underdocumentations of the 2 most commonly used CRC tests - colonoscopy and fecal occult blood testing - were rare. CONCLUSIONS: Use of claims data by health systems to measure CRC test use is a promising alternative to measuring CRC test use with medical chart review and may be used to identify unscreened patients for screening interventions and track screening trends over time.

Original languageEnglish (US)
Pages (from-to)99-103
Number of pages5
JournalAmerican Journal of the Medical Sciences
Volume345
Issue number2
DOIs
StatePublished - Feb 2013

Fingerprint

Colorectal Neoplasms
Safety
Health
Early Detection of Cancer
Occult Blood
Confidence Intervals
Colonoscopy
Documentation
Sigmoidoscopy
Information Storage and Retrieval
National Institutes of Health (U.S.)
Information Systems
Population

Keywords

  • Colorectal neoplasms
  • Early detection of cancer
  • Mass screening
  • Medically underserved area
  • Reproducibility of results

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Measurement of colorectal cancer test use with medical claims data in a safety-net health system. / Gupta, Samir; Tong, Liyue; Anderson, Paula; Rose, Bonnie; Carter, Elizabeth; Koch, Mark; Argenbright, Keith; Ahn, Chul; Allison, James; Skinner, Celette Sugg.

In: American Journal of the Medical Sciences, Vol. 345, No. 2, 02.2013, p. 99-103.

Research output: Contribution to journalArticle

Gupta, Samir ; Tong, Liyue ; Anderson, Paula ; Rose, Bonnie ; Carter, Elizabeth ; Koch, Mark ; Argenbright, Keith ; Ahn, Chul ; Allison, James ; Skinner, Celette Sugg. / Measurement of colorectal cancer test use with medical claims data in a safety-net health system. In: American Journal of the Medical Sciences. 2013 ; Vol. 345, No. 2. pp. 99-103.
@article{476805ab23f84138b0566cfc023cfd06,
title = "Measurement of colorectal cancer test use with medical claims data in a safety-net health system",
abstract = "BACKGROUND: Optimizing colorectal cancer (CRC) screening requires identification of unscreened individuals and tracking screening trends. A recent National Institutes of Health State of the Science Conference, {"}Enhancing Use and Quality of CRC Screening,{"} cited a need for more population data sources for measurement of CRC screening, particularly for the medically underserved. Medical claims data (claims data) are created and maintained by many health systems to facilitate billing for services rendered and may be an efficient resource for identifying unscreened individuals. The aim of this study, conducted at a safety-net health system, was to determine whether CRC test use measured by claims data matches medical chart documentation. METHODS: The authors randomly selected 400 patients from a universe of 20,000 patients previously included in an analysis of CRC test use based on claims data 2002-2006 in Tarrant Co, TX. Claims data were compared with medical chart documentation by estimation of agreement and examination of test use over/underdocumentation. RESULTS: The authors found that agreement on test use was very good for fecal occult blood testing (κ = 0.83, 95{\%} confidence interval: 0.75-0.90) and colonoscopy (κ = 0.91, 95{\%} confidence interval: 0.85-0.96) and fair for sigmoidoscopy (κ = 0.39, 95{\%} confidence interval: 0.28-0.49). Over- and underdocumentations of the 2 most commonly used CRC tests - colonoscopy and fecal occult blood testing - were rare. CONCLUSIONS: Use of claims data by health systems to measure CRC test use is a promising alternative to measuring CRC test use with medical chart review and may be used to identify unscreened patients for screening interventions and track screening trends over time.",
keywords = "Colorectal neoplasms, Early detection of cancer, Mass screening, Medically underserved area, Reproducibility of results",
author = "Samir Gupta and Liyue Tong and Paula Anderson and Bonnie Rose and Elizabeth Carter and Mark Koch and Keith Argenbright and Chul Ahn and James Allison and Skinner, {Celette Sugg}",
year = "2013",
month = "2",
doi = "10.1097/MAJ.0b013e31824dd1b6",
language = "English (US)",
volume = "345",
pages = "99--103",
journal = "The American journal of the medical sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Measurement of colorectal cancer test use with medical claims data in a safety-net health system

AU - Gupta, Samir

AU - Tong, Liyue

AU - Anderson, Paula

AU - Rose, Bonnie

AU - Carter, Elizabeth

AU - Koch, Mark

AU - Argenbright, Keith

AU - Ahn, Chul

AU - Allison, James

AU - Skinner, Celette Sugg

PY - 2013/2

Y1 - 2013/2

N2 - BACKGROUND: Optimizing colorectal cancer (CRC) screening requires identification of unscreened individuals and tracking screening trends. A recent National Institutes of Health State of the Science Conference, "Enhancing Use and Quality of CRC Screening," cited a need for more population data sources for measurement of CRC screening, particularly for the medically underserved. Medical claims data (claims data) are created and maintained by many health systems to facilitate billing for services rendered and may be an efficient resource for identifying unscreened individuals. The aim of this study, conducted at a safety-net health system, was to determine whether CRC test use measured by claims data matches medical chart documentation. METHODS: The authors randomly selected 400 patients from a universe of 20,000 patients previously included in an analysis of CRC test use based on claims data 2002-2006 in Tarrant Co, TX. Claims data were compared with medical chart documentation by estimation of agreement and examination of test use over/underdocumentation. RESULTS: The authors found that agreement on test use was very good for fecal occult blood testing (κ = 0.83, 95% confidence interval: 0.75-0.90) and colonoscopy (κ = 0.91, 95% confidence interval: 0.85-0.96) and fair for sigmoidoscopy (κ = 0.39, 95% confidence interval: 0.28-0.49). Over- and underdocumentations of the 2 most commonly used CRC tests - colonoscopy and fecal occult blood testing - were rare. CONCLUSIONS: Use of claims data by health systems to measure CRC test use is a promising alternative to measuring CRC test use with medical chart review and may be used to identify unscreened patients for screening interventions and track screening trends over time.

AB - BACKGROUND: Optimizing colorectal cancer (CRC) screening requires identification of unscreened individuals and tracking screening trends. A recent National Institutes of Health State of the Science Conference, "Enhancing Use and Quality of CRC Screening," cited a need for more population data sources for measurement of CRC screening, particularly for the medically underserved. Medical claims data (claims data) are created and maintained by many health systems to facilitate billing for services rendered and may be an efficient resource for identifying unscreened individuals. The aim of this study, conducted at a safety-net health system, was to determine whether CRC test use measured by claims data matches medical chart documentation. METHODS: The authors randomly selected 400 patients from a universe of 20,000 patients previously included in an analysis of CRC test use based on claims data 2002-2006 in Tarrant Co, TX. Claims data were compared with medical chart documentation by estimation of agreement and examination of test use over/underdocumentation. RESULTS: The authors found that agreement on test use was very good for fecal occult blood testing (κ = 0.83, 95% confidence interval: 0.75-0.90) and colonoscopy (κ = 0.91, 95% confidence interval: 0.85-0.96) and fair for sigmoidoscopy (κ = 0.39, 95% confidence interval: 0.28-0.49). Over- and underdocumentations of the 2 most commonly used CRC tests - colonoscopy and fecal occult blood testing - were rare. CONCLUSIONS: Use of claims data by health systems to measure CRC test use is a promising alternative to measuring CRC test use with medical chart review and may be used to identify unscreened patients for screening interventions and track screening trends over time.

KW - Colorectal neoplasms

KW - Early detection of cancer

KW - Mass screening

KW - Medically underserved area

KW - Reproducibility of results

UR - http://www.scopus.com/inward/record.url?scp=84873128757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873128757&partnerID=8YFLogxK

U2 - 10.1097/MAJ.0b013e31824dd1b6

DO - 10.1097/MAJ.0b013e31824dd1b6

M3 - Article

VL - 345

SP - 99

EP - 103

JO - The American journal of the medical sciences

JF - The American journal of the medical sciences

SN - 0002-9629

IS - 2

ER -